Literature DB >> 8356083

The N-terminal region of the 37-kDa translocated fragment of Pseudomonas exotoxin A aborts translocation by promoting its own export after microsomal membrane insertion.

C P Theuer1, J Buchner, D FitzGerald, I Pastan.   

Abstract

The 37-kDa C-terminal fragment of Pseudomonas exotoxin A (PE; termed PE37 and composed of aa 280-613 of PE) translocates to the cell cytosol to cause cell death. PE37 requires a C-terminal endoplasmic reticulum retention sequence to be cytotoxic, indicating that the toxin may translocate to the cytosol from the endoplasmic reticulum. We show here that the N-terminal region of nascent PE37 can be inserted into the membrane of canine pancreatic microsomes by the preprocecropin signal sequence but then is exported or released from microsomes. The 34 N-terminal amino acids of the toxin fragment are sufficient to arrest translocation and prevent the microsomal accumulation of nascent chains that otherwise are sequestered into microsomes. These data support a role for the N-terminal region of PE37 in the translocation of the toxin from the endoplasmic reticulum to the cytosol in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8356083      PMCID: PMC47225          DOI: 10.1073/pnas.90.16.7774

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  34 in total

Review 1.  Transport of proteins across the endoplasmic reticulum membrane.

Authors:  T A Rapoport
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

2.  Structural requirements for transport of preprocecropinA and related presecretory proteins into mammalian microsomes.

Authors:  G Schlenstedt; G H Gudmundsson; H G Boman; R Zimmermann
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

Review 3.  Recombinant toxins as novel therapeutic agents.

Authors:  I Pastan; V Chaudhary; D J FitzGerald
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 4.  Protein export in prokaryotes and eukaryotes. Theme with variations.

Authors:  H Wiech; P Klappa; R Zimmerman
Journal:  FEBS Lett       Date:  1991-07-22       Impact factor: 4.124

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Requirement of GTP hydrolysis for dissociation of the signal recognition particle from its receptor.

Authors:  T Connolly; P J Rapiejko; R Gilmore
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

7.  A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.

Authors:  C P Theuer; D FitzGerald; I Pastan
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.486

Review 8.  Recombinant toxins for cancer treatment.

Authors:  I Pastan; D FitzGerald
Journal:  Science       Date:  1991-11-22       Impact factor: 63.714

9.  Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol.

Authors:  M Ogata; C M Fryling; I Pastan; D J FitzGerald
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.486

10.  A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer.

Authors:  C P Theuer; D J FitzGerald; I Pastan
Journal:  J Urol       Date:  1993-06       Impact factor: 7.600

View more
  19 in total

1.  Ricin A chain without its partner B chain is degraded after retrotranslocation from the endoplasmic reticulum to the cytosol in plant cells.

Authors:  A Di Cola; L Frigerio; J M Lord; A Ceriotti; L M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

Review 2.  Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Clin Cancer Res       Date:  2011-10-15       Impact factor: 12.531

Review 3.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

4.  Thapsigargin-induced transport of cholera toxin to the endoplasmic reticulum.

Authors:  K Sandvig; O Garred; B van Deurs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome.

Authors:  E A Hughes; C Hammond; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

6.  Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.

Authors:  John F Langenheim; Wen Y Chen
Journal:  Breast Cancer Res Treat       Date:  2005-04       Impact factor: 4.872

7.  Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.

Authors:  D Rathore; J K Batra
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

Review 8.  Immunoconjugates in the management of hairy cell leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-09       Impact factor: 3.020

9.  Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.

Authors:  K Sandvig; M Ryd; O Garred; E Schweda; P K Holm; B van Deurs
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

Review 10.  Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Authors:  Robert J Kreitman
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.